You are viewing: France Carrier Screening Market analysis
Part of: Carrier Screening Market (Global)

The France Carrier Screening Market was valued at $113 Million in 2023 and projected to reach to $256.1 Million by 2028, representing a compound annual growth rate of 17.8%. France's carrier screening market is positioned for substantial growth through 2028, with the market nearly doubling in value over the forecast period.

France Carrier Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Carrier Screening Market Trends and Insights

  • France is experiencing accelerated adoption of carrier screening technologies driven by increasing awareness of genetic disorders, advances in molecular diagnostics, and supportive healthcare policies.
  • The market in France is projected to nearly double, reaching $256.1 million by 2028, reflecting a compound annual growth rate of 17.8%. The growth trajectory in France is underpinned by rising demand for prenatal and preconception screening services, coupled with improved reimbursement frameworks across French healthcare systems.
  • France's emphasis on preventive medicine and genetic counseling has positioned the country as a key market within Europe.
  • Enhanced accessibility to carrier screening tests and growing patient education initiatives are expected to sustain France's market expansion through the forecast period..

Key Market Statistics

  • CAGR (2023-2028) 17.8% CAGR
  • Market Size, 2023 ~USD 113 Million
  • Forecast, 2028 ~USD 256.1 Million
  • Country France

France Carrier Screening Market Overview

Market Valuation & Growth :

France's carrier screening market reached $113.0 million in 2023 and is projected to grow to $256.1 million by 2028, representing a robust 17.8% CAGR, outpacing many European peers.

Molecular Diagnostics Advancement :

French healthcare institutions are increasingly adopting advanced molecular diagnostic technologies for carrier screening, driven by investments in genetic testing infrastructure and laboratory capabilities.

Regulatory & Policy Support :

France's supportive healthcare policies and reimbursement frameworks for genetic screening services are accelerating market adoption among healthcare providers and patients seeking preventive genetic testing.

Rising Genetic Awareness :

Increased public and clinical awareness of genetic disorders, coupled with expanded prenatal and preconception screening programs, is driving demand for comprehensive carrier screening solutions across France.

France Carrier Screening Market Dynamics

  • This expansion is fueled by heightened awareness of genetic health risks, technological innovations in molecular diagnostics, and France's commitment to preventive healthcare.
  • Healthcare providers are increasingly integrating carrier screening into routine clinical practice, supported by favorable reimbursement policies and patient demand for personalized genetic risk assessment. The French market benefits from a well-established healthcare infrastructure and strong regulatory framework that encourages adoption of advanced diagnostic technologies.
  • Investment in genetic testing capabilities, coupled with growing collaboration between diagnostic laboratories and clinical institutions, will continue to drive market penetration.
  • By 2028, carrier screening is expected to become a standard component of preconception and prenatal care pathways across France..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • France's carrier screening market is valued at $113.0 million in 2023 and is forecast to reach $256.1 million by 2028.
      • France exhibits a strong 17.8% CAGR, reflecting accelerating adoption of genetic screening technologies and preventive healthcare initiatives.
      • Rising awareness of genetic disorders and improved reimbursement policies are primary growth catalysts driving market expansion in France.
      • France's commitment to preventive medicine and genetic counseling positions it as a leading European market for carrier screening services.

      Carrier Screening Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment PULMONARY CONDITIONS (Medical Condition)
      Forecast Period 2023-2028
      Growth Rate CAGR of 19.7% from 2023 to 2028
      Largest Segment SERVICES (Product & Service)
      Market Size Base Year (Billions) ~USD 2.2 (2023)
      Revenue Forecast (Billions) ~USD 5.4 (2028)
      Segments Covered Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028

      France Carrier Screening Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Customized Panel Testing
      • Expanded Carrier Screening
      • Predesigned Panel Testing
      • Targeted Disease Carrier Screening

      By Medical Condition

      • Hematological Conditions
      • Neurological Conditions
      • Other Medical Conditions
      • Pulmonary Conditions

      By Technology

      • Dna Microarrays
      • Dna Sequencing
      • Other Technologies
      • Pcr

      By End User

      • Clinical Laboratories
      • Fertility Clinics
      • Hospitals And Medical Centers
      • Other End Users

      By Product & 2021-2028

      • Products
      • Services

      FRANCE: CARRIER SCREENING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      CLINICAL LABORATORIES20.924.128.132.838.344.952.562.117.2
      FERTILITY CLINICS8.59.611.112.714.716.919.522.715.4
      HOSPITALS AND MEDICAL CENTERS49.457.968.480.995.7113.3134.4160.918.7
      OTHER END USERS4.34.85.56.2789.110.413.8
      TOTAL83.196.4113132.6155.7183215.4256.117.8

      Target Audience

      • Diagnostic Laboratory Operators : French diagnostic labs need market data to assess growth opportunities, benchmark performance against market trends, and plan capacity expansion for carrier screening services.
      • Medical Device & IVD Manufacturers : Companies developing carrier screening technologies require France-specific market intelligence to guide product development, regulatory strategy, and commercial launch planning in this high-growth market.
      • Healthcare Providers & Hospitals : French hospitals and clinics need market insights to justify investments in genetic screening programs, understand patient demand trends, and optimize service offerings aligned with market growth.
      • Investment & Private Equity Firms : Investors targeting the French healthcare diagnostics sector require validated market data and growth forecasts to evaluate acquisition targets, fund allocation, and portfolio company performance.
      • Healthcare Consultants & Advisors : Consulting firms advising French healthcare organizations need comprehensive market analysis to support strategic recommendations, competitive positioning, and market opportunity assessments.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for France's carrier screening market ($113.0M in 2023) with verified 17.8% CAGR projections through 2028, enabling accurate business planning and investment decisions.
      • France-Specific Competitive Intelligence : Gain detailed insights into the French market landscape, including key players, technology adoption rates, and competitive positioning specific to France's healthcare ecosystem and regulatory environment.
      • Reimbursement & Policy Analysis : Understand France's unique healthcare reimbursement policies, regulatory frameworks, and government support mechanisms driving carrier screening adoption and market expansion.
      • Strategic Market Entry Planning : Develop targeted go-to-market strategies for France with data-driven insights on market dynamics, customer segments, and growth opportunities specific to the French healthcare system.
      • Forecast-Driven Investment Decisions : Leverage comprehensive 5-year forecasts and market projections for France to identify optimal investment timing, resource allocation, and partnership opportunities in the carrier screening sector.

      Frequently asked questions

      What is the current size of the carrier screening market in France?

      As of 2023, France's carrier screening market is valued at $113.0 million, with expectations to grow substantially through 2028.

      What is the projected market size for carrier screening in France by 2028?

      France's carrier screening market is projected to reach $256.1 million by 2028, representing more than a doubling of the 2023 valuation.

      What is the CAGR for the carrier screening market in France?

      France's carrier screening market is growing at a compound annual growth rate of 17.8% from 2023 to 2028.

      What factors are driving growth in France's carrier screening market?

      Key drivers include increased awareness of genetic disorders, advances in molecular diagnostics, improved reimbursement frameworks, and France's emphasis on preventive healthcare.

      How does France's carrier screening market compare to global trends?

      France's 17.8% CAGR is competitive with global growth, demonstrating strong regional adoption of carrier screening technologies and supportive healthcare policies.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).

      The following is a breakdown of the primary respondents:

      Breakdown of Primary Participants:

      Carrier Screening Market  Size, and Share

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Carrier Screening Market  Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Carrier Screening Market  Size, and Share

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.

      Market Definition

      Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.

      Market Stakeholders

      • Carrier screening product manufacturers, vendors, and distributors
      • Carrier screening service companies
      • Hospitals and private physician clinics
      • Reference laboratories
      • Donor banks
      • Health insurance payers
      • Research & consulting firms
      • Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Clinical Laboratories
      • Distributors of Carrier Screening Products and services

      Report Objectives

      • To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)  
      • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
      • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
      • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
      • Geographic Analysis:  Further breakdown of the European Carrier Screening Market into specific countries.  

      Get the Full Carrier Screening Market Report

      Full forecast, segment splits, and company analysis for all Carrier Screening Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status